PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Is Prilosec the next Vioxx?



That's the question asked by Larry Ribstein, back from an Asian trip where heartburn was a first-hand worry. Of course, it's too early to even say that Vioxx is the next Vioxx, since we don't know whether Vioxx will follow the fen-phen (giant verdicts followed by giant verdicts and giant settlement and endless litigation) or Propulsid (giant well-publicized verdict reversed followed by settlement for a pittance) route. But Professor Ribstein has some good observations about the problems of letting lawyers dictate which drugs are in the market.

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.